First human trial tests 'Supercharged' donor cells against tough head & neck cancers
NCT ID NCT04290546
Summary
This early-stage study tested the safety of a new combination treatment for advanced head and neck cancer. It involved giving patients immune cells from a donor, along with several drugs, to see if the body could better fight the cancer. The main goal was to find a safe dose and understand the side effects, as this was the first time this specific combination was tried in people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.